Emilie M. Wigdor

Emilie M. Wigdor

Auto-generated profile, based on publicly available information

Emilie M. Wigdor

Institute of Developmental and Regenerative Medicine, Department of Paediatrics, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Cell
Verified
Journal Article
Open access
DVDragana Vuckovic
Dragana Vuckovic
EBErik L. Bao
Erik L. Bao
PAParsa Akbari
Parsa Akbari
CLCaleb A. Lareau
Caleb A. Lareau
AMAbdou Mousas
Abdou Mousas
NSNicole Soranzo
Nicole Soranzo
Blood cells play essential roles in human health, underpinning physiological processes such as immunity, oxygen transport, and clotting, which when perturbed cause a significant global health burden. Here we integrate data from UK Biobank and a large-scale international collaborative effort, including data for 563,085 European ancestry participants, and discover 5,106 new genetic variants independently associated with 29 blood cell phenotypes covering a range of variation impacting hematopoiesis. We holistically characterize the genetic architecture of hematopoiesis, assess the relevance of the omnigenic model to blood cell phenotypes, delineate relevant hematopoietic cell states influenced by regulatory genetic variants and gene networks, identify novel splice-altering variants mediating the associations, and assess the polygenic prediction potential for blood traits and clinical disorders at the interface of complex and Mendelian genetics. These results show the power of large-scale blood cell trait GWAS to interrogate clinically meaningful variants across a wide allelic spectrum of human variation.

15 May 2017 in Nature Genetics
Verified
Journal Article
Open access
PDF file
IGiPSYCH-Broad Autism Group
iPSYCH-Broad Autism Group
DWDaniel J Weiner
Daniel J Weiner
PGPsychiatric Genomics Consortium Autism Group
Psychiatric Genomics Consortium Autism Group
EWEmilie M Wigdor
Emilie M Wigdor
SRStephan Ripke
Stephan Ripke
ERElise B Robinson
Elise B Robinson
Elise Robinson and colleagues present the polygenic transmission disequilibrium test (pTDT) for evaluating transmission of polygenic risk in family-based study designs. The authors apply pTDT to a cohort of autism spectrum disorder (ASD) families and find that common polygenic variation acts additively with de novo variants to contribute to ASD risk. Autism spectrum disorder (ASD) risk is influenced by common polygenic and de novo variation. We aimed to clarify the influence of polygenic risk for ASD and to identify subgroups of ASD cases, including those with strongly acting de novo variants, in which polygenic risk is relevant. Using a novel approach called the polygenic transmission disequilibrium test and data from 6,454 families with a child with ASD, we show that polygenic risk for ASD, schizophrenia, and greater educational attainment is over-transmitted to children with ASD. These findings hold independent of proband IQ. We find that polygenic variation contributes additively to risk in ASD cases who carry a strongly acting de novo variant. Lastly, we show that elements of polygenic risk are independent and differ in their relationship with phenotype. These results confirm that the genetic influences on ASD are additive and suggest that they create risk through at least partially distinct etiologic pathways.

25 November 2019 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
ICiPSYCH-Broad Consortium
iPSYCH-Broad Consortium
FSF. Kyle Satterstrom
F. Kyle Satterstrom
RWRaymond K. Walters
Raymond K. Walters
TSTarjinder Singh
Tarjinder Singh
EWEmilie M. Wigdor
Emilie M. Wigdor
MDMark J. Daly
Mark J. Daly

8 June 2022 in Cell Genomics
Verified
Journal Article
Open access
EWEmilie M. Wigdor
Emilie M. Wigdor
DWDaniel J. Weiner
Daniel J. Weiner
JGJakob Grove
Jakob Grove
JFJack M. Fu
Jack M. Fu
WTWesley K. Thompson
Wesley K. Thompson
ERElise B. Robinson
Elise B. Robinson
Autism spectrum disorder (ASD) is diagnosed three to four times more frequently in males than in females. Genetic studies of rare variants support a female protective effect (FPE) against ASD. However, sex differences in common inherited genetic risk for ASD are less studied, particularly within families. Leveraging the Danish iPSYCH resource, we found siblings of female ASD cases (n = 1,707) had higher rates of ASD than siblings of male ASD cases (n = 6,270; p < 1.0 × 10-10). In the Simons Simplex and SPARK collections, mothers of ASD cases (n = 7,436) carried more polygenic risk for ASD than fathers of ASD cases (n = 5,926; 0.08 polygenic risk score [PRS] SD; p = 7.0 × 10-7). Further, male unaffected siblings under-inherited polygenic risk (n = 1,519; p = 0.03). Using both epidemiologic and genetic approaches, our findings strongly support an FPE against ASD's common inherited influences.

10 July 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
JTJacob L. Taylor
Jacob L. Taylor
JDJean-Christophe P. G. Debost
Jean-Christophe P. G. Debost
SMSarah U. Morton
Sarah U. Morton
EWEmilie M. Wigdor
Emilie M. Wigdor
HHHenrike O. Heyne
Henrike O. Heyne
ERElise B. Robinson
Elise B. Robinson
There are established associations between advanced paternal age and offspring risk for psychiatric and developmental disorders. These are commonly attributed to genetic mutations, especially de novo single nucleotide variants (dnSNVs), that accumulate with increasing paternal age. However, the actual magnitude of risk from such mutations in the male germline is unknown. Quantifying this risk would clarify the clinical significance of delayed paternity. Using parent-child trio whole-exome-sequencing data, we estimate the relationship between paternal-age-related dnSNVs and risk for five disorders: autism spectrum disorder (ASD), congenital heart disease, neurodevelopmental disorders with epilepsy, intellectual disability and schizophrenia (SCZ). Using Danish registry data, we investigate whether epidemiologic associations between each disorder and older fatherhood are consistent with the estimated role of dnSNVs. We find that paternal-age-related dnSNVs confer a small amount of risk for these disorders. For ASD and SCZ, epidemiologic associations with delayed paternity reflect factors that may not increase with age.

30 March 2023 in Science
Verified
Journal Article
Closed access
DPDuncan S. Palmer
Duncan S. Palmer
WZWei Zhou
Wei Zhou
LALiam Abbott
Liam Abbott
EWEmilie M. Wigdor
Emilie M. Wigdor
NBNikolas Baya
Nikolas Baya
BNBenjamin M. Neale
Benjamin M. Neale
Classical statistical genetics theory defines dominance as any deviation from a purely additive, or dosage, effect of a genotype on a trait, which is known as the dominance deviation. Dominance is well documented in plant and animal breeding. Outside of rare monogenic traits, however, evidence in humans is limited. We systematically examined common genetic variation across 1060 traits in a large population cohort (UK Biobank, N = 361,194 samples analyzed) for evidence of dominance effects. We then developed a computationally efficient method to rapidly assess the aggregate contribution of dominance deviations to heritability. Lastly, observing that dominance associations are inherently less correlated between sites at a genomic locus than their additive counterparts, we explored whether they may be leveraged to identify causal variants more confidently.